Teleflex Incorporated (NYSE:TFX) Shares Acquired by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. boosted its stake in Teleflex Incorporated (NYSE:TFX) by 7.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,096 shares of the medical technology company’s stock after buying an additional 757 shares during the period. GHP Investment Advisors Inc.’s holdings in Teleflex were worth $2,744,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. acquired a new position in Teleflex during the 1st quarter valued at about $2,467,000. ProShare Advisors LLC increased its position in Teleflex by 34.1% in the 1st quarter. ProShare Advisors LLC now owns 12,200 shares of the medical technology company’s stock valued at $2,759,000 after acquiring an additional 3,105 shares during the period. Tidal Investments LLC raised its stake in Teleflex by 214.7% during the 1st quarter. Tidal Investments LLC now owns 6,644 shares of the medical technology company’s stock valued at $1,503,000 after acquiring an additional 4,533 shares in the last quarter. Boston Trust Walden Corp boosted its position in Teleflex by 2.7% during the 2nd quarter. Boston Trust Walden Corp now owns 233,913 shares of the medical technology company’s stock worth $49,199,000 after acquiring an additional 6,076 shares during the period. Finally, Russell Investments Group Ltd. grew its stake in shares of Teleflex by 15.8% in the first quarter. Russell Investments Group Ltd. now owns 18,838 shares of the medical technology company’s stock worth $4,245,000 after purchasing an additional 2,570 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Price Performance

Shares of NYSE:TFX opened at $233.63 on Friday. The company’s fifty day moving average is $241.03 and its two-hundred day moving average is $223.68. The company has a market cap of $11.00 billion, a P/E ratio of 37.50, a price-to-earnings-growth ratio of 2.15 and a beta of 1.16. Teleflex Incorporated has a 12-month low of $177.63 and a 12-month high of $257.85. The company has a quick ratio of 1.44, a current ratio of 2.58 and a debt-to-equity ratio of 0.36.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, topping analysts’ consensus estimates of $3.33 by $0.09. The firm had revenue of $749.70 million during the quarter, compared to analyst estimates of $762.98 million. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The business’s quarterly revenue was up .9% compared to the same quarter last year. During the same period last year, the company posted $3.41 EPS. Equities analysts expect that Teleflex Incorporated will post 13.97 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend was Thursday, August 15th. Teleflex’s payout ratio is presently 21.83%.

Insider Buying and Selling at Teleflex

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of Teleflex stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total transaction of $638,898.82. Following the completion of the sale, the director now owns 5,496 shares of the company’s stock, valued at $1,313,159.28. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 1.43% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on TFX. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $205.00 to $245.00 in a research note on Monday, July 1st. Truist Financial increased their price target on Teleflex from $247.00 to $255.00 and gave the company a “hold” rating in a research note on Monday, October 14th. Stephens upped their price objective on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. Finally, Royal Bank of Canada lifted their target price on Teleflex from $260.00 to $275.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Teleflex currently has a consensus rating of “Moderate Buy” and a consensus price target of $268.86.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.